Explore Our Library of Biomanufacturing Resources & Technical Data

Application Notes

Cellastim S – Reconstitution Application Note

rHSA Reconstitution Video Protocol

Expansion of Adherent HEK293T Cells in Flasks in Chemically Defined Cell Culture Media

High-Resolution Analytical Characterization of Optibumin®: Structural Homogeneity and Functional Consistency Compared to Plasma-Derived HSA

Lentivirus Production Protocol in Serum-Free Conditions – How To Improve Transfection Efficiency and Titer Yield

Preserving Lentiviral Titer During Sterile Filtration Using Recombinant Albumin

Recombinant Albumin Improves Lentiviral Vector Recovery After Freeze-Thaw Stress

rHSA Improves Infectious Lentiviral Titer Yield During Tangential Flow Filtration by Passivating Filter Surfaces

Transient Transfection Protocol – Enhancement of Transfection Efficiency Using Recombinant Transferrin with Serum-Free HEK293 Media

Blog

Albumin in Drug Delivery: Cancer’s Unexpected Achilles’ Heel

Beyond Synthetic Surfactants: The Case for Recombinant Human Serum Albumin (rHSA) as an Ideal Alternative to Poloxamer 188

Controlling Impurities in Cell Culture Media

Evolving Challenges in Closed-System Biomanufacturing

High-Performance Production of Viral Vectors for Cell and Gene Therapy Using OptiPEAK HEK293t Complete Media

How Regulatory Bodies Are Driving the Shift to Animal-Origin-Free Solutions in Cell Therapy and Vaccine Development

Innovative Solutions in Closed-System Biomanufacturing: Exploring the Tools and Technologies Driving Sterility and Efficiency

Optibumin vs Traditional Albumin: Comparing Performance in Cell Wash Applications

Why Do Some Biologics Cross the Finish Line—While Others Crash and Burn?

Catalog

InVitria Product Catalog

Data Sheets

Cellastim S – Data Sheet

Exbumin – Data Sheet

ITS Animal-Free – Data Sheet

ITSE Animal-Free – Data Sheet

ITSE+A Animal-Free – Data Sheet

Lacromin – Data Sheet

Optibumin 20 – Data Sheet

Optibumin 25 – Data Sheet

Optiferrin – Data Sheet

News

InVitria and Cellevate Partner on Vaccine Manufacturing

InVitria Presents ASGCT 2026 Data on rHSA for Lentiviral Vector Manufacturing

Posters

Adherent HEK293t Cells Cultured in Pall’s iCELLis® Bioreactor with OptiPEAK HEK293t Blood-Free Chemically Defined Media Exhibit Robust and Rapid Population Doubling Times

Recombinant Albumin Enhances Lentiviral Vector Stability During Downstream Processing

Virus Yield Improvement for Downstream Processing: Exbumin®, Excipient Recombinant Albumin

Product Brochures

ITSE AF – Brochure

Optiferrin – Product Brochure

Product Specifications

ITS – Specifications

SDS

Exbumin – Safety Data Sheet

ITS AF – Safety Data Sheet

ITSE AF – Safety Data Sheet

ITSE+A – Safety Data Sheet

Lacromin – Safety Data Sheet

Lysobac – Safety Data Sheet

Optibumin 20 – Safety Data Sheet

Optibumin 25 – Safety Data Sheet

Optiferrin – Safety Data Sheet

Cellastim S – Safety Data Sheet

Use Guidelines

Cellastim S – Guidelines for Use

Exbumin – Guidelines for Use

ITS – Guidelines for Use

ITSE AF – Guidelines for Use

ITSE+A – Guidelines for Use

Lacromin – Guidelines for Use

Optibumin 20 – Guidelines for Use

Optibumin 25 – Guidelines for Use

Optiferrin – Guidelines for Use

Webinar

Accelerating Vaccine Development Through Use of Blood-Free Components

White Papers

Emergence of Blood-Free Recombinant Human Albumin

Process Optimization for Lentivirus Production in the iCELLis® Nano Using a Chemically Defined, Animal Component Free HEK293 Media